SBIR-STTR Award

Microchips of Protein Kinase Substrates
Award last edited on: 7/6/11

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$2,060,317
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Xiaochuan Zhou

Company Information

Atactic Technologies Inc

2575 West Bellfort Suite 270
Houston, TX 77054
   (713) 664-8188
   info@atactictech.com
   www.atactictech.com
Location: Single
Congr. District: 09
County: Harris

Phase I

Contract Number: 1R43GM076941-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2006
Phase I Amount
$299,567
The long term goal of the proposed technology development is to take the current applications of the protein kinase (PK) substrate chips to the level suitable for proteome-scale applications and for developing clinical diagnostics. Recent years have witnessed dramatic expansion in our understanding of PK biology. In addition to the manifested intricate networks of the interactions often simultaneously or sequentially involving multiple PK enzymes which may target more than one protein, PK associations with human diseases are well-documented and more than 200 PKs are linked to human disease loci. To be able to effectively address the questions associated with these complex systems, multiplexing assay/screening technologies based on specific PK substrates have become increasingly important. Currently, only a limited number of PK assay choices are available and these are mostly low throughput or only for qualitatively assessment of substrate-kinase activities and specificities; there is no supporting platform for the proteome-scale multiplexing profiling and mapping of specific PK substrates in tens of thousands of sequences. Therefore, the development of a robust, quantitative, comprehensive, and high throughput PK assay platform is a significant step for addressing the rising needs, and moreover, a quantitative approach for enzymatic reaction measurements on peptide microchips will be promising for enabling clinical diagnosis applications. We propose the development of novel microchips of PK substrates and methods to fulfill these requirements. We have a collaboration team with expertise in microfabrication of bioassay devices, parallel synthesis, peptide chemistry, cell signaling, and cell biology ensuring useful assays to be developed and the in vitro microchip experimental results verified in in vivo systems. At the completion of the project (phases I and II), the catalog and custom PK substrate peptide microchips for quantitative, parallel measurements of the activities of a list of kinases against proteome-scale substrate sequences will be close to the market for research use. The established methods of on-chip assays will be used for high throughput PK specificity mapping, PK profiling, novel PK identification, PK inhibitor screening, and the development of diagnostic applications

Phase II

Contract Number: 5R43GM076941-02
Start Date: 3/15/06    Completed: 3/14/09
Phase II year
2007
(last award dollars: 2010)
Phase II Amount
$1,760,750

The long term goal of the proposed technology development is to take the current applications of the protein kinase (PK) substrate chips to the level suitable for proteome-scale applications and for developing clinical diagnostics. Recent years have witnessed dramatic expansion in our understanding of PK biology. In addition to the manifested intricate networks of the interactions often simultaneously or sequentially involving multiple PK enzymes which may target more than one protein, PK associations with human diseases are well-documented and more than 200 PKs are linked to human disease loci. To be able to effectively address the questions associated with these complex systems, multiplexing assay/screening technologies based on specific PK substrates have become increasingly important. Currently, only a limited number of PK assay choices are available and these are mostly low throughput or only for qualitatively assessment of substrate-kinase activities and specificities; there is no supporting platform for the proteome-scale multiplexing profiling and mapping of specific PK substrates in tens of thousands of sequences. Therefore, the development of a robust, quantitative, comprehensive, and high throughput PK assay platform is a significant step for addressing the rising needs, and moreover, a quantitative approach for enzymatic reaction measurements on peptide microchips will be promising for enabling clinical diagnosis applications. We propose the development of novel microchips of PK substrates and methods to fulfill these requirements. We have a collaboration team with expertise in microfabrication of bioassay devices, parallel synthesis, peptide chemistry, cell signaling, and cell biology ensuring useful assays to be developed and the in vitro microchip experimental results verified in in vivo systems. At the completion of the project (phases I and II), the catalog and custom PK substrate peptide microchips for quantitative, parallel measurements of the activities of a list of kinases against proteome-scale substrate sequences will be close to the market for research use. The established methods of on-chip assays will be used for high throughput PK specificity mapping, PK profiling, novel PK identification, PK inhibitor screening, and the development of diagnostic applications.

Public Health Relevance:
This Public Health Relevance is not available.

Thesaurus Terms:
Peptide, Protein Kinase Acid, Base, Bioassay, Biology, Catalog, Cell, Cell Biology, Chemical Property, Chemistry, Choice, Cyclic Peptide, Density, Diagnosis, Dimer, Enzyme, Family, Health /Scientific Organization, Human, Lighting, Measurement, Model, Phosphorylation, Protein, Serine, Success, Technology /Technique Development, Threonine, Tyrosine